Global Cardiac Rhythm Management Devices Market, by Type (Defibrillator, Cardiac Resynchronization T

Published Date: April 2019 | Report Code : HC1910266

The Global Cardiac Rhythm Management Devices Market is projected to reach USD 41.67 billion by 2028, at a CAGR of 7.0% during a forecast period.

The management of cardiac rhythm is part of electrophysiology used to control the heart’s functioning. The last decade has seen continuing evolution and the use of systems for managing cardiac rhythm, including cardiovascular resynchronization therapy, pacemakers, implantable cardioverter defibrillators, and loop recorders. General practitioners (GP) are increasingly involved in the follow-up and management of patients with these devices. Certain factors that are driving the market growth include the increasing cases of cardiovascular disorders, technological advancements, rise in the use of ambulatory and home services for cardiac monitoring, and favorable reimbursement policies.

Global Cardiac Rhythm Management Market

According to the World Health Organization (WHO), globally, cardiovascular diseases account for more than 30% of the total deaths. Nearly 33.5 million individuals worldwide also suffer from atrial fibrillation (AFib), the most prevalent type of severe arrhythmia. With the rise in the aging population in the US and Europe, the number of patients suffering from heart rhythm disorders is likely to grow. However, therapeutic radiation used in cancer treatment can influence the operation of a patient with implantable cardiac rhythm devices. The implantable device technology uses complementary metal-oxide-semiconductor (CMOS), which is vulnerable to damage by the therapeutic doses of radiation but can vary according to the type of the device in use. This is one of the major factors that limits the scope of using cardiac rhythm management devices, as implants are highly sensitive and their malfunctioning may have serious consequences. Moreover, high cost of these devices with limited insurance coverage is hampering the market growth.

Global Cardiac Rhythm Management Market

Based on type, the cardiac rhythm management devices market has been segmented into defibrillator, cardiac resynchronization therapy devices, and pacemakers. The defibrillator segment is expected to account for the largest market share during the forecast period. As per the American Heart Association (AHA), survival from cardiac arrest doubled when bystanders used a publicly-available automated external defibrillator (AED). Cardiac arrest victims who received a shock from a publicly-available AED had far more chances of survival and being discharged from the hospital than those who did not, accounting for 66.5% versus 43%, respectively. Therefore, it has been estimated that about 1,700 lives are saved in the US every year using a defibrillator. This indicates that the usage of defibrillators has experienced a significant rise, globally, over the recent years.

North America is expected to account for the largest market share for cardiac rhythm management devices. This is mainly due to the developed of healthcare infrastructure, government initiatives, and rising incidence of arrhythmia demanding more cardiac implants. According to a report by the US CDC, more than 75,000 hospitalizations can be attributed to atrial fibrillation. Moreover, it is highlighted that a large part of the US population suffers from atrial fibrillation. Therefore, it is expected to rise further during the forecast period. This market in the Asia Pacific is expected to witness high growth due to the rising healthcare expenditure by governments of APAC countries, increasing cases of cardiac disorders, and growing per capita income of the population of the South Asian countries.

Key Factors Impacting Market Growth:

  • The increasing number of heart disorders across various age groups
  • Increasing demand from ambulatory care and home care
  • Rising expenditures of governments on the healthcare sector
  • The high cost of these devices with limited insurance coverage

Key Developments:

  • In February 2017, Abbott (US) announced the US Food and Drug Administration (FDA) approval of conditional labeling for magnetic resonance (MR) for both, the Assurity MRI pacemaker and the Tendril MRI pacing lead.
  • In January 2019, MicroPoort CRM (US) announced the first implants of its new pacemaker families, Eno™ and Teo™. The product features automatic MRI programming that is practical for patients and doctors, possibly reducing the expenses produced by workflows in hospitals.

What This Study Provides:

  • Global market and submarket forecast covering the period of 2016 to 2028, with accompanying analysis
  • Regional market and submarket forecast covering the period of 2016 to 2028, with accompanying analysis
  • National market and submarket forecast covering the period of 2016 to 2028, with accompanying analysis
  • Extensive details and analysis of contracts, projects, and program
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Analysis of game-changing technological trends and how these will shape the industry
  • Explanation or political, regulatory and technical factors to consider
  • Barriers to entry analysis for markets around the world
  • Profiles of leading companies operating within the sector with market share analysis
  • SWOT analysis of the market, together with the opportunities available and the key threats faced
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • Market conclusions & recommendations

Market Segmentation:

By Type:

  • Defibrillator
  • Cardiac Resynchronization Therapy Devices
  • Pacemakers

By End User:

  • Hospitals
  • Home Care
  • Ambulatory Care

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Type
    • By End User
  • Western Europe:
    • By Country (Germany, UK, France, Spain, Rest of Western Europe)
    • By Type
    • By End User
  • Eastern Europe:
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Type
    • By End User
  • Asia Pacific
    • By Country (China, Japan, India, Rest of Asia Pacific)
    • By Type
    • By End User
  • Middle East:
    • By Country (UAE, Qatar, Iran, Saudi Arabia, Rest of Middle East)
    • By Type
    • By End User
  • Rest of the World
    • By Region (Latin America, Brazil, Rest of the World)
    • By Type
    • By End User

Companies Covered: Abbott, Abiomed, Biotronik SE & Co KG, Boston Scientific Corporation, Koninklijke Philips NV, MicroPort CRM, LivaNova Plc, Medtronic PPLC, Pacetronix, SchillerAG, Shenzhen Mindray Biomedical Electronics Co. Ltd, and Zoll Medical Corporation...

Years Considered In The Study

 

Historic Year

2016, 2017

Base Year

2018

Forecast Period

2019-2028 

CAGR %(2019-2028)

7.0

 

Key Questions Answered By This Report:

  • How is the cardiac rhythm management devices market evolving?
  • What is driving and restraining cardiac rhythm management devices' dynamics?
  • How will each cardiac rhythm management device submarket segment grow over the forecast period and how much Sales will these submarkets account for in 2028?
  • How will market shares of each cardiac rhythm management devices submarket develop from 2019-2028?
  • Which cardiac rhythm management devices submarket will be the main driver of the overall market from 2019-2028?
  • How will political and regulatory factors influence regional cardiac rhythm management devices markets and submarkets?
  • Will leading national cardiac rhythm management devices broadly follow macroeconomic dynamics, or will individual country sectors outperform the rest of the economy?
  • How will market shares of the national markets change by 2028 and which nation will lead the market in 2028?
  • Who are the leading players and what are their prospects over the forecast period?

Reasons to Buy This Report:

  • Market size estimation of the global cardiac rhythm management devices market on a regional and global basis
  • The unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy